-
No Through Road
Cancer cells are able to find new pathways around targeted therapies. Scientists are racing to get there first.
by Sue Rochman
-
Healthy Habits
It Takes All KindsA variety of vegetables and fruit can help reduce your cancer risk
by Marci A. Landsmann
-
Forward Look
Fueling the Pediatric Cancer PipelineNew efforts are needed to push the pace of drug development.
by Leah Lawrence
-
Forward Look
Telling the TaleQ&A with medical oncologist Siddhartha Mukherjee, the Pulitzer Prize-winning author of The Emperor of All Maladies.
by Sue Rochman
-
Forward Look
The Proof of the Proton Is in the ResultProton beam radiation therapy is expensive and controversial.
by Stephen Ornes
-
Forward Look
The Whole BeanStudies present a mixed picture of coffee's influence on cancer risk.
by Yvonne Lee
-
Forward Look
Melanoma Indoor Tanning Link ConfirmedTeens and young adults face heightened risk from tanning beds.
by Yvonne Lee
-
Forward Look
A Paycheck Linked to Cancer?Studies on workplace exposures show continued health risks.
by Corinna Wu
-
When Cancer Rings Twice
One out of every six people diagnosed with cancer this year will be facing it for, at least, the second time.
by Melissa Weber
-
Changing the Face of Clinical Trials
Efforts are under way to increase African-American enrollment in cancer clinical trials.
by Leslie Harris O'Hanlon
Cancer Talk
Cancer Vaccines Show Promise in Early Trials
While mRNA vaccines offer a personalized approach to triggering an immune response, peptide vaccines could be a one-size-fits-all treatment. Researchers are exploring both options.
by Thomas Celona
Declining Breast Cancer Mortality in Younger WomenU.S. breast cancer deaths declined for women ages 20 to 49, which researchers credit to wider screening and better treatment.
by Kevin McLaughlin
Missed Activities Due to Cancer-related Fatigue and DepressionWomen were more likely than men to have fatigue or depression linked to cancer, and both effects were linked to people withdrawing from physical activities.
by Eric Fitzsimmons
Immunotherapy Improves Results in Head and Neck CancerCombining an immune checkpoint inhibitor with standard care extended event-free survival by nearly two years.
by Thomas Celona